RITM

ANALYST NOTE: RITHM CAPITAL CORP. (RITM) DATE: 2026-06-20 CURRENT PRICE: $9.19

1. Structural Readiness

• Conservative Entry: Not yet defined (requires confirmed breakout).
• Aggressive/Pre-Breakout Entry: Not recommended for conservative sizing; current price ($9.19) represents a holding zone pending confirmation.
• Breakout Level: Not yet established.
• Current Price: $9.19.
• Extension: Not applicable (no breakout occurred).
• ATR Context: Current ATR is 2.2% (sub-threshold). This indicates lower volatility than the historical "sweet spot" (4–6%), suggesting the market is currently in a consolidation or low-conviction phase rather than a high-momentum expansion.

2. Thesis Layer

• Thesis Classification: TACTICAL / SETUP-LED.
• Macro Context: There is no named secular thesis attached to this name as of 2026-06-20. The investment case is not driven by a broad macro theme (e.g., "AI Infrastructure" or "Green Energy Transition") but is instead judged strictly on the quality of the technical setup (the forming coil) and the underlying business fundamentals.
• Conviction Weighting: Conviction is derived from the alignment of the forming technical structure with the company's operational improvements and margin expansion, rather than a top-down macro tailwind.

3. Business Overview

Rithm Capital Corp. operates as a diversified real estate finance company with four primary segments: Origination and Servicing, Residential Transitional Lending, Asset Management, and Investment Portfolio.

• Origination & Servicing (Newrez): As of the 2026-02-19 filing, Newrez ranks in the top five U.S. lenders and servicers by volume and unpaid principal balance (UPB). The company originates conventional, government-insured, and non-conforming loans for sale and securitization.
• *Evidence:* E8, E16.
• *Financials:* The segment recognized $208.25 million in gains on originated residential loans held-for-sale in the most recent period, up from $159.79 million previously (E11).
• Asset Management: The company manages approximately $63 billion in assets as of December 31, 2025 (E19), with daily fund inflows continuing (E7).
• *Strategic Expansion:* In December 2025, Rithm acquired Crestline for $324.7 million to expand into private credit, fund liquidity, and insurance strategies (E13, E17). Crestline Life and Insurance Annuity Company issues single premium immediate annuities (E12).
• *Commercial Real Estate:* In December 2025, Rithm acquired Paramount for $1.8 billion, adding Class A office assets and owner-operator capabilities to its commercial real estate platform (E18).
• Operational Efficiency & Guidance:
• *Production:* Management expects production volume between $6.5 billion and $7.0 billion for the current year (E1).
• *EBITDA:* Management projects EBITDA between $150 million and $175 million for the current year (E2).
• *Cost Reduction:* The company estimates total annual expense savings in excess of $65 million, reducing the cost per loan by 15% to $93 (E4).
• *Technology:* The transition to the Valon operating system is on track for early 2027 (E3).
• Market Context:
• *San Francisco:* Activity was the strongest since 2019, with availability declining 600 basis points year-over-year (E6).
• *Macro Volume:* The Mortgage Bankers Association estimated 2025 origination volume at $2.0 trillion (up from $1.7 trillion in 2024) and forecast 2026 volume at $2.2 trillion (E20).
• *Headwinds:* Housing supply/demand imbalances persist, and mortgage rates remained in the 6–7% range throughout 2025, creating affordability pressures (E22, E23).

4. Archetype and Conviction

• Archetype: Deep Value Recovery.
• *Rationale:* The company is trading at a price ($9.19) that appears to reflect a recovery in earnings power and asset quality following a period of market dislocation. The acquisition of Crestline and Paramount, combined with the Valon transition, suggests a structural re-rating of the asset base.
• Valuation & Fundamentals:
• The company is generating significant gains on loan sales ($208M) and projecting $150M–$175M in EBITDA.
• Cost savings of $65M+ provide a clear margin inflector.
• The AUM base has grown to $63B, indicating successful capital deployment.
• Conviction Stack:
• *Thesis Strength:* Moderate (Tactical, no macro tailwind).
• *Evidence Quality:* High (Multiple primary filings and earnings transcripts from 2026).
• *Structural Quality:* Moderate (Forming coil, sub-threshold ATR).
• *Setup Readiness:* Partial (Forming, awaiting breakout).
• *Rerating Potential:* High, contingent on the successful integration of Crestline/Paramount and the realization of the $65M cost savings.
• ATR Analysis: The current ATR of 2.2% is sub-threshold (<2.5%), indicating low volatility. This is consistent with a "forming" coil where the market is digesting the recent acquisitions and earnings guidance. It does not yet signal the high-conviction momentum (4–6% ATR) required for a confirmed breakout.

5. Invalidations, Strengths, and Gaps

• What Would Strengthen: A confirmed breakout above the current resistance (price action moving significantly higher with volume), or management raising the EBITDA guidance above the $175M upper bound.
• Gaps in Evidence:
• Specific Valuation Metrics: The provided evidence lacks explicit P/E, P/NAV, or dividend yield data for 2026-06-20.
• Debt Maturity Schedule: While the 2030 Senior Notes are mentioned, the full maturity profile and refinancing risks for 2026-2027 are not detailed in the provided snippets.
• Interest Rate Sensitivity: While rates are noted as 6-7%, the specific impact of rate changes on the $63B AUM and loan origination volumes is not quantified in the evidence.

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: medium Key evidence: Management guidance of $150M-$175M EBITDA and $6.5B-$7B production; $65M+ annual cost savings projected; Newrez ranking top 5 in US origination/servicing. Key risks: Sub-threshold ATR (2.2%) indicates weak momentum; mortgage rates remaining at 6-7% may suppress affordability; integration risk of $1.8B Paramount and $324M Crestline acquisitions. Sizing hint: Position size should be reduced relative to confirmed breakouts due to the "forming" status and low volatility. Expected path: Price consolidates near $9.19 while management executes the Valon transition and cost-saving initiatives; a breakout requires a catalyst such as a beat on EBITDA or a broader rate cut. Expected horizon: 3 to 6 months for a potential breakout or invalidation.